Dose Shield Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Dose Shield General Information

Description

Developer and distributor of hospital medication equipment. The company manufactures and distributes an automatic dose-drawing machine, with applications for nuclear cardiology, radio pharmaceuticals and related products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 8651 Catlr Park Drive
  • Suite 500
  • Markleville, IN 46056
  • United States
Primary Industry
Other Devices and Supplies
Other Industries
Outcome Management (Healthcare)
Acquirer
Vertical(s)
Corporate Office
  • 8651 Catlr Park Drive
  • Suite 500
  • Markleville, IN 46056
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dose Shield Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dose Shield‘s full profile, request access.

Request a free trial

Dose Shield Executive Team (1)

Name Title Board Seat
John Zehner Founder & President
To view Dose Shield’s complete executive team members history, request access »

Dose Shield Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Dose Shield‘s full profile, request access.

Request a free trial

Dose Shield FAQs

  • Who is the founder of Dose Shield?

    John Zehner is the founder of Dose Shield.

  • Where is Dose Shield headquartered?

    Dose Shield is headquartered in Markleville, IN.

  • What industry is Dose Shield in?

    Dose Shield’s primary industry is Other Devices and Supplies.

  • Is Dose Shield a private or public company?

    Dose Shield is a Private company.

  • What is the current valuation of Dose Shield?

    The current valuation of Dose Shield is 00.00.

  • What is Dose Shield’s current revenue?

    The current revenue for Dose Shield is 000000.

  • Who are Dose Shield’s investors?

    NukeMed has invested in Dose Shield.

  • When was Dose Shield acquired?

    Dose Shield was acquired on 11-Jun-2008.

  • Who acquired Dose Shield?

    Dose Shield was acquired by Positron.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »